» Articles » PMID: 23107345

Effects of Corticosteroid on the Expressions of Neuropeptide and Cytokine MRNA and on Tenocyte Viability in Lateral Epicondylitis

Overview
Publisher Biomed Central
Date 2012 Oct 31
PMID 23107345
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled:

Background: The purpose of this study was to determine the reaction mechanism of corticosteroid by analyzing the expression patterns of neuropeptides (substance P (SP), calcitonin gene related peptide (CGRP)) and of cytokines (interleukin (IL)-1α, tumor growth factor (TGF)-β) after corticosteroid treatment in lateral epicondylitis. In addition, we also investigated whether corticosteroid influenced tenocyte viability.

Methods: The corticosteroid triamcinolone acetonide (TAA) was applied to cultured tenocytes of lateral epicondylitis, and the changes in the mRNA expressions of neuropeptides and cytokines and tenocyte viabilities were analyzed at seven time points. Quantitative real-time polymerase chain reaction and an MTT assay were used.

Results: The expression of SP mRNA was maximally inhibited by TAA at 24 hours but recovered at 72 hours, and the expressions of CGRP mRNA and IL-1α mRNA were inhibited at 24 and 3 hours, respectively. The expression of TGF-β mRNA was not significant. Tenocyte viability was significantly reduced by TAA at 24 hours.

Conclusions: We postulate that the reaction mechanism predominantly responsible for symptomatic relief after a corticosteroid injection involves the inhibitions of neuropeptides and cytokines, such as, CGRP and IL-1α. However the tenocyte viability was compromised by a corticosteroid.

Citing Articles

Lipids, lipid-lowering drugs and lateral epicondylitis of the humerus: a drug-targeted Mendelian randomization study.

Liu M, Chen X, Bao X, Huang B Front Genet. 2024; 15:1437712.

PMID: 39286458 PMC: 11402682. DOI: 10.3389/fgene.2024.1437712.


What factors influence pain scores following Corticosteroid injection in patients with Greater Trochanteric Pain Syndrome? A systematic review.

Foxcroft B, Stephens G, Woodhead T, Ayre C BMC Musculoskelet Disord. 2024; 25(1):149.

PMID: 38365672 PMC: 10874005. DOI: 10.1186/s12891-024-07217-3.


The 100 most cited articles in lateral epicondylitis research: A bibliometric analysis.

Zhu S, He Z, Bi Q, Cao L, Gu H, Zhang Q Front Surg. 2023; 9:913818.

PMID: 36860728 PMC: 9968860. DOI: 10.3389/fsurg.2022.913818.


Direct Effect of Local Cryotherapy on Muscle Stimulation, Pain and Strength in Male Office Workers with Lateral Epicondylitis, Non-Randomized Clinical Trial Study.

Radecka A, Lubkowska A Healthcare (Basel). 2022; 10(5).

PMID: 35628016 PMC: 9140546. DOI: 10.3390/healthcare10050879.


The expression of substance P and calcitonin gene-related peptide is associated with the severity of tendon degeneration in lateral epicondylitis.

Han S, Kim H, Jang Y, Lee H, Rhie J, Han D BMC Musculoskelet Disord. 2021; 22(1):210.

PMID: 33612098 PMC: 7898744. DOI: 10.1186/s12891-021-04067-1.


References
1.
Maffulli N, Testa V, Capasso G, Ewen S, Sullo A, Benazzo F . Similar histopathological picture in males with Achilles and patellar tendinopathy. Med Sci Sports Exerc. 2004; 36(9):1470-5. DOI: 10.1249/01.mss.0000139895.94846.8d. View

2.
Galliani I, Burattini S, Mariani A, Riccio M, Cassiani G, Falcieri E . Morpho-functional changes in human tendon tissue. Eur J Histochem. 2002; 46(1):3-12. DOI: 10.4081/1649. View

3.
Klein M, Yalamanchi N, Pham H, Longaker M, Chang J . Flexor tendon healing in vitro: effects of TGF-beta on tendon cell collagen production. J Hand Surg Am. 2002; 27(4):615-20. DOI: 10.1053/jhsu.2002.34004. View

4.
Angeli A, Masera R, Sartori M, Fortunati N, Racca S, Dovio A . Modulation by cytokines of glucocorticoid action. Ann N Y Acad Sci. 1999; 876:210-20. DOI: 10.1111/j.1749-6632.1999.tb07641.x. View

5.
Lambert M, St Clair Gibson A, Noakes T . Rupture of the triceps tendon associated with steroid injections. Am J Sports Med. 1995; 23(6):778. DOI: 10.1177/036354659502300626. View